Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy (FIRST)
2015年2月27日 更新者:Volcano Corporation
Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy: The FIRST Study
This is a multi-center, prospective registry of patients with intermediate coronary lesions defined as a stenosis of 40-80% by angiography.
Approximately 300 patients will be enrolled into the study at sites in the United States and Europe.
There will be no follow up beyond hospital discharge in this study.
A sub-group of 30 patients will undergo Adenosine MRI.
The investigators hypothesize that Intravascular Ultrasound Radiofrequency (IVUS RF) anatomical criteria, such as minimal luminal area, plaque burden and virtual histology plaque type, can predict physiological ischemia by Fractional Flow Reserve (FFR).
研究概览
地位
完全的
条件
详细说明
Patients undergoing cardiac catheterization must meet clinical inclusion and exclusion criteria and sign an informed consent.
At the time of catheterization the patients will be further analyzed for eligibility using angiographic inclusion and exclusion criteria.
Patients who fulfilled the clinical and angiographic criteria will undergo further imaging evaluation using an IVUS RF catheter (Volcano Therapeutics) and FFR wire (Radi or Volcano).
The decision for treatment of any lesion will be at the operator's discretion.
For patients enrolled at Washington Hospital Center and do not undergo percutaneous coronary intervention, an assessment with non invasive perfusion adenosine MRI also be performed.
研究类型
观察性的
注册 (实际的)
350
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
District of Columbia
-
Washington、District of Columbia、美国、20010
- Washingtoon Hospital Center
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 75年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
取样方法
非概率样本
研究人群
Patients required to have an intermediate coronary lesion (stenosis 40-80% by visual estimate) in one or more native, major epicardial coronary artery with reference diameter ≥2.5mm (visual estimate)
描述
Inclusion Criteria:
- Sign written informed consent to participate in the study.
- Clinical indication for coronary angiography for stable or unstable angina
Specific Angiographic Inclusion Criteria:
- Patients required to have an intermediate coronary lesion (stenosis 40-80% by visual estimate) in one or more native, major epicardial coronary artery with reference diameter ≥2.5mm (visual estimate)
- The vessel(s) with the intermediate lesion must have no flow limiting lesions and must be available for imaging and must be considered safe for imaging evaluation.
Exclusion Criteria:
- Patient has had a documented acute ST-segment elevation myocardial infarction within the past 24 hours
- Decompensated heart failure or hypotension requiring intubation, inotropes, intravenous diuretics or intraaortic balloon counterpulsation.
- Renal dysfunction (creatinine clearance < 60 mL/min/1.73m2)
- Pregnancy or breast-feeding
- Standard contra-indications to MRI for implanted ferro-magnetic devices - i.e.: pacemakers, defibrillator (AICD), and aneurysm clips
- Body weight > 400lbs
- Left ventricular hypertrophy >1.5cm by by echocardiogram
- History of bronchospasm or asthma
- ECG evidence of conduction defect, including 2nd or 3rd degree AVB
- Patient has a known hypersensitivity, allergy or contraindication to gadolinium-based contrast agents.
- Prior participation in this study or patient is currently enrolled in another investigational use device or drug study that has not reached its primary endpoint. If the patient is enrolled in another study that is not investigational, required visits for that trial must not interfere with the conduct of this trial.
Angiographic Exclusion Criteria:
- Unprotected left main lesion location.
- Ostial lesion
- Angiographic evidence of severe calcification or marked tortuosity of the target vessel that would preclude safe imaging
- Lesion is located within or distal to an arterial or saphenous vein graft.
- Angiographic presence of thrombus in the lesion or vessel studied.
- Lesion in a vessel with <2.5 mm reference diameter or with more than one lesion in the vessel
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Intermediate coronary lesions
Diagnostic device: FFR Diagnostic device: IVUS RF At participating centers, FFR and IVUS are standard of care diagnostic procedures for patients with intermediate (40-80% angiographic stenosis by visual estimate). Both modalities were used regularly for such patients whether or not they are participants in this clinical study. In FIRST, the decision to perform percutaneous coronary intervention (PCI) was left to the discretion of the investigator, and was not dictated by the clinical protocol. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Correlation between (Minimum Luminal Area) MLA and FFR
大体时间:Day of Procedure
|
The correlation between MLA and FFR; and the threshold value for MLA corresponding to an FFR < 0.8.
|
Day of Procedure
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Correlation between FFR and IVUS and VH parameters
大体时间:Day of Procedure
|
Correlation between FFR and various IVUS measurements (MLA,area stenosis, lesion length, plaque burden) and VH parameters (plaque type and presence of a TCFA)
|
Day of Procedure
|
|
Association of FFR and Cut-off of MLA
大体时间:Day of Procedure
|
Assess the association between FFR <0.75 and 0.8 and determined cut-off of MLA with presence of a Thin Cap Fibro-Atheroma(TCFA) and/or plaque burden ≥70%
|
Day of Procedure
|
|
Identify risk score model
大体时间:1 year
|
To identify a risk score model taking into account IVUS measurements (MLA, plaque burden, area stenosis, lesion length) and VH parameters (plaque type and presence of TCFA) associated with FFR < 0.8
|
1 year
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Ron Waksman, MD、Medstar Health Research Institute
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2010年9月1日
初级完成 (实际的)
2012年6月1日
研究完成 (实际的)
2012年6月1日
研究注册日期
首次提交
2010年6月28日
首先提交符合 QC 标准的
2010年6月29日
首次发布 (估计)
2010年6月30日
研究记录更新
最后更新发布 (估计)
2015年3月4日
上次提交的符合 QC 标准的更新
2015年2月27日
最后验证
2015年1月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.